Atlas Trials

Efficacy and Safety of Parecoxib vs. Indomethacin in Preventing Post-ERCP Pancreatitis

Clinical trial NCT06623513 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06623513
Sponsor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Pancreatitis, AcuteCholangiopancreatography, Endoscopic Retrograde
Start date
2024-10-01
Primary completion
2026-09-30
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.